Other languages Aptamer Group plc

Equities

APTA

GB00BNRRP542

Market Closed - London S.E. Other stock markets 11:40:17 2024-05-10 am EDT			5-day change	1st Jan Change
0.73 ^GBX	+17.74%		+8.15%	-36.52%

Apr. 22	EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings	AN
Apr. 18	Aptamer inks new Optimer+ transplant rejection therapy partnership	AN

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings	Apr. 22
Aptamer inks new Optimer+ transplant rejection therapy partnership	Apr. 18
Aptamer Group Files Patent Application for Optimer Binders	Apr. 08
Aptamer submits patent application for Optimer binders	Apr. 08
EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles	Mar. 28
Aptamer Group plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 28
Zentek Says Potential COVID-19 Drug Shows 'Promising' Safety Profile in Preclinical Trial	Mar. 25
Aptamer shares jump on successful Unilever contract progression	Mar. 11
Aptamer Group, Unilever Prepare to Patent Optimers Developed Under Partnership	Mar. 11
Aptamer says new Optimer+ delivers improved results	Feb. 27
Aptamer Group plc Announces R&D Progress on New Optimer®? + Platform	Feb. 27
Aptamer and Neuro-Bio begin Alzheimer's test development second phase	Feb. 22
Aptamer Group, Neuro-Bio Enter Second Phase of Partnership for Alzheimer's Flow Test Development	Feb. 22
Aptamer shares plunge as half-year revenue to fall by 70%	Feb. 05
Aptamer Group plc Provides Revenue Guidance for the First Half of the Fiscal Year 2024	Feb. 05
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	Jan. 17
Aptamer inks deal for Optimer discovery with biotech firm	Dec. 14
Aptamer Group Signs Optimer Discovery Deal With Genetic Medicines Company	Dec. 14
Aptamer Group plc Announces Material Agreement with Genetic Medicines Company	Dec. 14
Zentek's COVID-19 Aptamer Successfully Tested Against Omicron Variant in Pre-Clinical Study	Nov. 29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aptamer Group plc

Equities

APTA

GB00BNRRP542

Other languages

Filters